logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11261222 B1

PDFFull Text
Date of Patent:
Mar. 01, 2022

Filed:

Nov. 05, 2020

Transdermal peptide with nuclear localization ability and use thereof

Applicant:

Soochow University, Suzhou, CN;

Inventors:

Shuyu Zhang, Suzhou, CN;

Jianping Cao, Suzhou, CN;

Daojiang Yu, Suzhou, CN;

Wei Zhu, Suzhou, CN;

Assignee:

SOOCHOW UNIVERSITY, Suzhou, CN;

Attorney:

SZDC Law P.C.

Primary Examiner:

Julie Ha

Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 38/16 (2006.01); A61K 38/00 (2006.01); A61K 47/42 (2017.01); A61K 47/62 (2017.01); A61P 17/00 (2006.01); C07K 14/47 (2006.01); C07K 14/00 (2006.01); A61K 49/00 (2006.01); C12N 9/02 (2006.01);
U.S. Cl.
CPC ...
C07K 14/47 (2013.01); A61K 47/62 (2017.08); A61K 49/0043 (2013.01); A61K 49/0056 (2013.01); A61P 17/00 (2018.01); C12N 9/0089 (2013.01); C12Y 115/01001 (2013.01); A61K 38/00 (2013.01); C07K 2319/60 (2013.01);
Abstract

A transdermal peptide with a nuclear localization ability and having an amino acid sequence as shown in SEQ ID NO: 1 is disclosed. A fusion protein including a macromolecular protein with one end being linked to the transdermal peptide is also disclosed. The transdermal peptide can be used in the preparation of a medicament or a transdermal preparation for treating skin diseases. A medicament for treating a skin disease includes the transdermal peptide and a pharmaceutically acceptable excipient. The transdermal peptide enters the cells autonomously to locate in the nuclei, and can penetrate through the stratum corneum of the skin into cells in the dermis. The peptide is conveniently synthesized artificially and suitable for transdermal administration, and has a therapeutic potential via transdermal administration by carrying a drug for treating skin diseases.

Find Patent Forward Citations

Zhang, Shuyu. (2022). Transdermal peptide with nuclear localization ability and use thereof (U.S. Patent No. 11261222). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11261222

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…